Thursday, May 14, 2020 7:08:43 PM
Minus the hit piece and the screw-ups of the conference call, the actual transcript confirms all we were hoping for, minus an announcement of a buyout. Revenue is solid and is increasing. Sales are positive going forward. Just the one week of sales exceeded the revenue of all of last year.
We may continue some painful short selling in the near term, but for the next year we look solid.
All the more reasons I will continue to hold.
Opti
We may continue some painful short selling in the near term, but for the next year we look solid.
All the more reasons I will continue to hold.
Opti
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
Recent CODX News
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City • PR Newswire (US) • 04/02/2026 01:00:00 PM
- This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase • AllPennyStocks.com • 03/31/2026 09:59:22 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:10:33 PM
- Co-Diagnostics Reports Full Year 2025 Financial Results • PR Newswire (US) • 03/31/2026 08:01:00 PM
- Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization • PR Newswire (US) • 03/25/2026 12:00:00 PM
- Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia • PR Newswire (US) • 03/20/2026 12:00:00 PM
- Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast • PR Newswire (US) • 03/17/2026 01:00:00 PM
- Co-Diagnostics to Present at Medical Korea 2026 • PR Newswire (US) • 03/16/2026 01:00:00 PM
- Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies • PR Newswire (US) • 03/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2026 05:23:23 PM
- Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships • PR Newswire (US) • 01/12/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 02:15:26 PM
- Co-Diagnostics Announces Reverse Stock Split • PR Newswire (US) • 12/30/2025 02:00:00 PM
- Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies • PR Newswire (US) • 12/29/2025 02:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 09:30:38 PM
- Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India • PR Newswire (US) • 12/18/2025 02:00:00 PM
- Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation • PR Newswire (US) • 12/17/2025 02:00:00 PM
- Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 • PR Newswire (US) • 12/09/2025 02:00:00 PM
- Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India • PR Newswire (US) • 12/08/2025 05:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 09:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2025 10:47:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2025 10:31:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2025 10:31:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2025 10:31:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2025 10:29:24 PM
